• Why TrialAssure
  • Products
    • BEACON
    • REGISTRY
    • Clinical Data Anonymization Software | ANONYMIZE DS
    • Clinical Data Anonymization Tools | ANONYMIZE R
    • LINK
  • Service Solutions
  • News
  • Resources
    • Transparent Thinking Blog
    • Registry Snapshots
  • Request Free Demo
  • TrialResults
  • Careers
  • Contact Us
TrialAssure
Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

by pachaary@mmsholdings.com | Dec 14, 2015 | Blog

Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma by Kasim McLain, Senior Medical Writer/Transparency LeadPosted on 12/14/2015 Both the Food and Drug Administration (FDA) and independent research groups have highlighted the lack of...

Recent Posts

  • This week in transparency news: May 30 – June 12, 2020
  • FDA Furthers Transparency Push with CSR Release Pilot
  • This week in transparency news: May 16 – May 29, 2020
  • This week in transparency news: May 2 – May 15, 2020
  • This week in transparency news: April 18 – May 1, 2020

Tags

Anonymization ANZCTR blockchain Brazilian Clinical Trials Registry brexit Chinese Clinical Trial Registry Clincal Trial Data clinical data Clinical Disclosure Reporting Clinical Research Information Service Clinical Study Reports Clinical Trial Clinical Trial Disclosure clinical trial registration clinical trial reporting clinical trials ClinicalTrials.gov Clinical Trials and Submissions Data Clinical Trials Information Management process Clinical Trials Transparency Clinical Trial Transparency Compliance Data Sharing Disclosure of Clinical Trial Results EMA EUCTR EudraCT FDA FDAAA FDAMA Final Rule Global Registries Good Pharma Scorecard health canada ICMJE Lay Summaries open science movement Redaction Registration and Results Reporting Sunshine Act Transparency Transparency News TrialAssure News Trial Disclosure World Health Organization
© Copyright TrialAssure. All rights reserved.